Neonatal diabetes -: The role of KCNJ11 (Kir6.2)

被引:0
|
作者
Tammaro, Paolo [1 ]
机构
[1] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ATP-sensitive potassium (K-ATP) channels are inhibited by intracellular ATP and activated by MgADP. As a consequence, they couple the metabolic state of the cell to its electrical activity. In pancreatic P-cells KATp channels regulate glucose-dependent insulin secretion and are the target for sulphonylurea drugs clinically employed in the treatment of type 2 diabetes. This review discusses recent advances in our understanding of the role of KATp channels in permanent neonatal diabetes mellitus. Copyright (C) 2007 S. Karger AG, Basel.
引用
收藏
页码:70 / 82
页数:13
相关论文
共 50 条
  • [21] Functional analysis of two Kir6.2 (KCNJ11) mutations, K170T and E322K, causing neonatal diabetes
    Tarasov, A. I.
    Girard, C. A.
    Larkin, B.
    Tammaro, P.
    Flanagan, S. E.
    Ellard, S.
    Ashcroft, F. M.
    DIABETES OBESITY & METABOLISM, 2007, 9 : 46 - 55
  • [22] Functional effects of mutations at F35 in the NH2-terminus of Kir6.2 (KCNJ11), causing neonatal diabetes, and response to sulfonylurea therapy
    Proks, Peter
    Girard, Christophe
    Baevre, Halvor
    Njolstad, Pal R.
    Ashcroft, Frances M.
    DIABETES, 2006, 55 (06) : 1731 - 1737
  • [23] Association of the antihypertensive response of iptakalim with KCNJ11 (Kir6.2 gene) polymorphisms in Chinese Han hypertensive patients
    Rui-feng Duan
    Wen-yu Cui
    Hai Wang
    Acta Pharmacologica Sinica, 2011, 32 : 1078 - 1084
  • [24] KCNJ11 gene knockout of the Kir6.2 KATP channel causes maladaptive remodeling and heart failure in hypertension
    Kane, Garvan C.
    Behfar, Atta
    Dyer, Roy B.
    O'Cochlain, D. Fearghas
    Liu, Xiao-Ke
    Hodgson, Denice M.
    Reyes, Santiago
    Miki, Takashi
    Seino, Susumu
    Terzic, Andre
    HUMAN MOLECULAR GENETICS, 2006, 15 (15) : 2285 - 2297
  • [25] Association of the antihypertensive response of iptakalim with KCNJ11 (Kir6.2 gene) polymorphisms in Chinese Han hypertensive patients
    Duan, Rui-feng
    Cui, Wen-yu
    Wang, Hai
    ACTA PHARMACOLOGICA SINICA, 2011, 32 (08) : 1078 - 1084
  • [26] Permanent neonatal diabetes due to paternal germline mosaicism for an activating mutation of the KCNJ11 gene encoding the Kir6.2 subunit of the β-cell potassium adenosine triphosphate channel
    Gloyn, AL
    Cummings, EA
    Edghill, EL
    Harries, LW
    Scott, R
    Costa, T
    Temple, IK
    Hattersley, AT
    Ellard, S
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (08): : 3932 - 3935
  • [27] Glibenclamide Unresponsiveness in a Brazilian Child with Permanent Neonatal Diabetes Mellitus and DEND Syndrome Due to a C166Y Mutation in KCNJ11 (Kir6.2) Gene
    Della Manna, Thais
    Batristim, Claudilene
    Radonsky, Vanessa
    Savoldelli, Roberta D.
    Damiani, Durval
    Kok, Fernando
    Pearson, Ewan R.
    Ellard, Sian
    Hattersley, Andrew T.
    Reis, Andre F.
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2008, 52 (08) : 1350 - 1355
  • [28] The C42R mutation in the Kir6.2 (KCNJ11) gene as a cause of transient neonatal diabetes, childhood diabetes, or later-onset, apparently type 2 diabetes mellitus
    Yorifuji, T
    Nagashima, K
    Kurokawa, K
    Kawai, M
    Oishi, M
    Akazawa, Y
    Hosokawa, M
    Yamada, Y
    Inagaki, N
    Nakahata, T
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (06): : 3174 - 3178
  • [29] An Egyptian case of congenital hyperinsulinism of infancy due to a novel mutation in KCNJ11 encoding Kir6.2 and response to octreotide
    Sherif, Eman M.
    Abdelmaksoud, Abeer A.
    Elbarbary, Nancy S.
    Njolstad, Pal Rasmus
    ACTA DIABETOLOGICA, 2013, 50 (05) : 801 - 805
  • [30] Effects of a Diet Supplemented with Fruit Antioxidants (Mango) on the Expression of Kir6.2 (KCNJ11) in the Hippocampus and Kidney of Diabetic Rats
    Romo-Robles, D. P.
    Dominguez-Avila, J. A.
    Montiel-Herrera, M.
    Ayala-Zavala, J. F.
    Astiazaran-Garcia, H.
    Gonzalez-Aguilar, G. A.
    NEUROPHYSIOLOGY, 2020, 52 (06) : 430 - 437